Background: The 2003 European Society of Hypertension/European Society of Cardiology (ESH-ESC) guidelines have recently proposed a new risk stratification scheme for estimating absolute risk for cardiovascular disease. At variance from the previous 1999 World Health Organization–International Society of Hypertension (WHO/ISH) guidelines, the new criteria include some additional risk factors such as obesity, abnormal high-density (HDL) or low-density lipoprotein (LDL) cholesterol levels and define a slight increase in creatinine and microalbuminuria as signs of target organ damage (TOD). Objective: The aim of the study was to assess overall cardiovascular risk in uncomplicated hypertensives according to the 2003 ESH-ESC guidelines comparing ...
Because of new evidence on several diagnostic and therapeutic aspects of hypertension, the present g...
In June 2013 the European Society of Hypertension (ESH) / European Society of Cardiology (ESC) publi...
For many years decisions to treat or not treat hypertension with drugs were made consideringthe leve...
The 20032 European Society of Hypertesion/European Society Cardiology (ESH-ESC)guidelines have recen...
The 2007 guidelines on hypertension of the European Society of Hypertension (ESH) and the European S...
BACKGROUND: The European Society of Hypertension (ESH) guidelines recommend two possible strategies ...
To evaluate in a large population of untreated, uncomplicated essential hypertensives the relationsh...
The following is a brief statement of the 2003 European Society of Hypertension (ESH)-European Socie...
The following is a brief statement of the 2003 European Society of Hypertension (ESH)-European Socie...
Because of new evidence on several diagnostic and therapeutic aspects of hypertension, the present g...
The aim of this study was to investigate retinal and peripheral microvascular function in asymptomat...
Because of new evidence on several diagnostic and therapeutic aspects of hypertension, the present g...
Clinical evaluation of cardiovascular risk in patients with hypertension is evolving from independen...
Previous studies suggest that up to 60% of all patients with hypertension receive inappropriate trea...
Because of new evidence on several diagnostic and therapeutic aspects of hypertension, the present g...
In June 2013 the European Society of Hypertension (ESH) / European Society of Cardiology (ESC) publi...
For many years decisions to treat or not treat hypertension with drugs were made consideringthe leve...
The 20032 European Society of Hypertesion/European Society Cardiology (ESH-ESC)guidelines have recen...
The 2007 guidelines on hypertension of the European Society of Hypertension (ESH) and the European S...
BACKGROUND: The European Society of Hypertension (ESH) guidelines recommend two possible strategies ...
To evaluate in a large population of untreated, uncomplicated essential hypertensives the relationsh...
The following is a brief statement of the 2003 European Society of Hypertension (ESH)-European Socie...
The following is a brief statement of the 2003 European Society of Hypertension (ESH)-European Socie...
Because of new evidence on several diagnostic and therapeutic aspects of hypertension, the present g...
The aim of this study was to investigate retinal and peripheral microvascular function in asymptomat...
Because of new evidence on several diagnostic and therapeutic aspects of hypertension, the present g...
Clinical evaluation of cardiovascular risk in patients with hypertension is evolving from independen...
Previous studies suggest that up to 60% of all patients with hypertension receive inappropriate trea...
Because of new evidence on several diagnostic and therapeutic aspects of hypertension, the present g...
In June 2013 the European Society of Hypertension (ESH) / European Society of Cardiology (ESC) publi...
For many years decisions to treat or not treat hypertension with drugs were made consideringthe leve...